OCTOBER 3-5, 2013 AT HILTON BEIRUT HABTOOR GRAND
Transcription
OCTOBER 3-5, 2013 AT HILTON BEIRUT HABTOOR GRAND
Under the High Patronage of His Excellency the Minister of Public Health Mr. Ali Hassan Khalil OCTOBER 3-5, 2013 AT HILTON BEIRUT HABTOOR GRAND HOTEL, LEBANON DEAR COLLEAGUES, As I write this welcome, we have again a little turmoil in the region. However, it is important to remember that we owe it to our patients, to Lebanon and to the scientific community to go on. Most of all, we owe it to our faithful attendees, from many countries of the region, who look forward every year to this event. In this spirit, a large debt of gratitude is due to our sponsors, to the scientific and organizing committees and to our distinguished speakers. With their support we have put together a rich program of very high caliber. Thank you for your support to the Lebanese Society of Hematology and Blood transfusion and to Lebanon. I am sure we will have a wonderful time and fruitful meeting. Miguel R. ABBOUD MD, MHA President of the Lebanese Society of Hematology and Blood transfusion INTERNATIONAL SPEAKERS LSH SCIENTIFIC COMMITTEE Günter AUERSWALD MD,PhD GERMANY Miguel R. ABBOUD MD, MHA Alain BEAUPLET MD FRANCE Ali BAZARBACHI MD, PhD, MHA Yves BERTRAND MD, PhD FRANCE Berthe CHALHOUB HACHEM MD Gregory CHENG MD, PhD HONG KONG Bertrand COIFFIER MD, PhD FRANCE Thierry FACON MD FRANCE Ahmad IBRAHIM MD Nidal JOUMAA MD Claudia DJAMBAS KHAYAT MD Peter NOUN MD Pierre FENAUX MD, PhD FRANCE Jean Pierre SAAB MD Ephraim FUCHS MD, MBA USA Hanady SAMAHA MD Olivier HERMINE MD, PhD FRANCE Ali TAHER MD, PhD, FRCP Alfonso IORIO MD, PhD, FRCP CANADA Rezan KADIR MD, FRCS, MRCOG UL LSH EXECUTIVE COMMITTEE Mohamed KHARFAN DABAJA MD USA Miguel R. ABBOUD MD, MHA PRESIDENT Odile OBERLIN MD FRANCE Isaac ODAME MB, ChB, MRCP, FRCPath, FRCPC CANADA Yves PIQUET MD FRANCE Alok STRIVASTAVA MD, FRACP, FRCPA, FRCP INDIA Hanady SAMAHA MD VICE PRESIDENT Peter NOUN MD PAST PRESIDENT Berthe CHALHOUB HACHEM MD SECRETARY Claudia DJAMBAS KHAYAT MD TREASURER Ahmad IBRAHIM MD MEMBER René TARDIVEL MD FRANCE Nidal JOUMAA MD MEMBER Swee Lay THEIN MB, BS, FRCPath, FRCP, DSC, FMedSci UK Jean Pierre SAAB MD MEMBER THURSDAY OCTOBER 3 13:30-14:00 REGISTRATION 14:00-14:30 OPENING CEREMONY Welcome note: President of the Lebanese Society of Hematology and Blood transfusion Miguel R. ABBOUD Word of the Lebanese Minister of Public Health Mr. Ali Hassan KHALIL 14:30-16:00 TRANSFUSION SESSION:LAUNCHING OF NEW NATIONAL GUIDELINES* Organized by: The Lebanese Ministry of Public Health In collaboration with: Lebanese Society of Hematology and Blood Transfusion Lebanese Syndicate of Clinical Pathologists Introduction Rita FEGHALI Word from the Department of Health and “Etablissement Français du sang - EFS” Alain BEAUPLET Implementation of good manufacturing practices in blood transfusion in Lebanon Yves PIQUET Good manufacturing practices in blood component preparation René TARDIVEL Update on emerging pathogens in blood transfusion Yves PIQUET Efficacy of platelet transfusion in hematology René TARDIVEL * Simultaneous translation available 16:00-17:30 EDUCATIONAL SESSION I: BLEEDING DISORDERS IN WOMEN Joint session with Lebanese Society for Obstetrics and Gynecology In Collaboration with World Federation of Hemophilia 16:00-16:30 Women with bleeding disorders – pregnancy complications and management Rezan KADIR 16:30-17:00 DDAVP & tranexamic acid revisited Günter AUERSWALD 17:00-17:30 Inherited bleeding disorders in women – improving diagnosis and treatment Rezan KADIR 17:30-18:00 COFFEE BREAK 18:00-18:40 NOVARTIS ONCOLOGY SYMPOSIUM Recent Advances in the Management of Non-Transfusion-Dependent Thalassemia (NTDT) Ali TAHER 18:40-19:10 EDUCATIONAL SESSION II: HEMOGLOBINOPATHIES 18:40-19:10 Global Network in Sickle Cell Disease Isaac ODAME FRIDAY OCTOBER 4 09:00-10:30 EDUCATIONAL SESSION III: HEMOGLOBINOPATHIES 09:00-09:30 New clinical trials in Sickle Cell Disease Swee Lay THEIN 09:30-10:00 Global perspectives in Sickle Cell Disease Isaac ODAME 10:00-10:30 Stem cells Transplant in Hemoglobinopathies Ephraim FUCHS 10:30-11:00 COFFEE BREAK 11:00-12:30 EDUCATIONAL SESSION IV: HEMOPHILIA STATE OF THE ART TREATMENT In Collaboration with World Federation of Hemophilia 11:00-11:30 Assessment need for good care Alok STRIVASTAVA 11:30-12:00 Building evidence based optimal treatment in hemophilia: where are we at? An epidemiologic perspective Alfonso IORIO 12:00-12:30 Joint health in Hemophilia Alok STRIVASTAVA 12:30-13:15 SPECIAL SYMPOSIUM Evolving New Opportunities in Hemophilia Günter AUERSWALD Sponsored with an unrestricted grant from Novo Nordisk 13:15-14:30 LUNCH 14:30-16:00 EDUCATIONAL SESSION V: PEDIATRIC LYMPHOMA 14:30-15:00 Hodgkin Lymphoma in Pediatric Patients Odile OBERLIN 15:00-15:30 Lymphoblastic lymphoma in Pediatric patients Yves BERTRAND 15:30-16:00 Late effects of therapy in Pediatric Hodgkin Lymphoma Odile OBERLIN 16:00-16:50 EDUCATIONAL SESSION VI: PLATELETS AND COAGULATION 16:00-16:25 Prevention of recurrent VTE: optimal duration or personalized treatment? Afonso IORIO 16:25-16:50 Investigational agents in Aplastic Anemia Gregory CHENG 16:50-17:30 COFFEE BREAK 17:30-18:15 GSK CHRONIC ITP SYMPOSIUM Gregory CHENG 18:15-19:00 ROCHE SYMPOSIUM Speaker TBD SATURDAY OCTOBER 5 09:00-10:00 EDUCATIONAL SESSION VII: MULTIPLE MYELOMA 09:00-09:30 First line therapy in Multiple Myeloma Mohamad Kharfan DABAJA 09:30-10:00 Management of relapse-refractory multiple myeloma Thierry FACON 10:00-12:00 EDUCATIONAL SESSION VIII: LEUKEMIA AND MYELODYSPLASIA 10:00-10:30 State of the art management of myelodysplasia Pierre FENAUX 10:30-11:00 Pediatric ALL: update Yves BERTRAND 11:00-11:30 Treatment of acute promyelocytic leukemia: where do we stand? Pierre FENAUX 11:30-12:00 New drugs in CLL Mohamad Kharfan DABAJA 12:00-12:30 COFFEE BREAK 12:30-14:00 EDUCATIONAL SESSION IX: ADULT LYMPHOMA 12:30-13:00 Diffuse large B cell lymphoma Bertrand COIFFIER 13:00-13:30 Mantle cell lymphoma Olivier HERMINE 13:30-14:00 New drugs in lymphoma Bertrand COIFFIER 14:00-15:00 LUNCH 15:00-16:00 EDUCATIONAL SESSION X: PRESIDENTIAL SYMPOSIUM 15:00-15:30 Haploidentical Bone Marrow Transplants: From bench to bedside Ephraim FUCHS 15:30-16:00 Infectious Complications in BMT, Focus on fungal infections Speaker TBD 16:00-16:30 COFFEE BREAK 16:30-17:30 PRESIDENTIAL SYMPOSIUM 16:30-17:00 Modulation of fetal Hemoglobin Swee Lay THEIN 17:00-17:30 Basic Science lecture: Pathophysiology of thalassemia Olivier HERMINE The Lebanese Society of Hematology and Blood Transfusion wishes to express its gratitude to the following companies for their generous contribution: GOLD SPONSORS SILVER SPONSOR OTHER SPONSORS Astra Zeneca Merck Sharp and Dohme Benta Pharma Industries BPI Pacific Pharma S.A.L. Boehringer Ingelheim Georges N. Khoriaty Foundation Glaxo Smithkline Janssen Pharmamed Pierre Fabre Medicament - Oncology Division Pfizer Khayat-Kanaan for Medical Equipment Sanofi LFB Biomedicaments Union Pharmaceutique D’orient s.a.l www.lshbt.org